GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Change In Other Working Capital

NKGen Biotech (NKGen Biotech) Change In Other Working Capital : $-0.02 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Change In Other Working Capital?

NKGen Biotech's Change In Other Working Capital for the quarter that ended in Mar. 2024 was $0.09 Mil. It means NKGen Biotech's Other Working Capital increased by $0.09 Mil from Dec. 2023 to Mar. 2024 .

NKGen Biotech's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was $-0.39 Mil. It means NKGen Biotech's Other Working Capital declined by $0.39 Mil from Dec. 2022 to Dec. 2023 .

NKGen Biotech Change In Other Working Capital Historical Data

The historical data trend for NKGen Biotech's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Change In Other Working Capital Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Change In Other Working Capital
-0.09 -0.44 -0.39

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Change In Other Working Capital Get a 7-Day Free Trial -0.12 -0.11 - -0.11 0.09

NKGen Biotech Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NKGen Biotech Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

NKGen Biotech (NKGen Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Change In Other Working Capital
Comparable Companies
OCUP CASI SPRO XLO NGM GBIO ASMB CCCC OCEA FIXX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
Website
https://www.nkgenbiotech.com
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.